Korea Investment Partners
Overview
Korea Investment Partners is an Asian venture capital and private equity firm, and an affiliate of Korea Investment Holdings, that invests in companies from early to growth stages across various industries, including biotech, healthcare, media, fintech, and ICT.
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| GGWP | Apr 2026 | Series A | Lead |
| Curigin Co., Ltd. | May 2019 | Series A | Co-investor |
| PDC*line Pharma | Jan 2020 | Debt | Co-investor |
| Xpanner | May 2026 | Series B Extension | Lead |
| Supervillain Labs | May 2024 | Seed | Co-investor |
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
FAQ
Where is Korea Investment Partners based?
Korea Investment Partners is headquartered in Seoul, South Korea.
When was Korea Investment Partners founded?
Korea Investment Partners was founded in 1986.
How many portfolio companies does Korea Investment Partners have?
Korea Investment Partners has 5 portfolio companies in Caplight's dataset.
What are some companies in Korea Investment Partners's portfolio?
Portfolio companies visible on Caplight include GGWP, Curigin Co., Ltd., PDC*line Pharma, Xpanner, Supervillain Labs.
What was Korea Investment Partners's most recent investment shown here?
Korea Investment Partners's most recent investment in this portfolio sample was in Xpanner in 2026.
What sectors does Korea Investment Partners focus on?
Korea Investment Partners focuses on Healthcare & Life Sciences, Healthcare & Life Sciences, Media, Entertainment & Gaming, AI, Data & Cloud Infrastructure, Frontier & Industrial Tech, Enterprise Software, Crypto & Web3, Media, Entertainment & Gaming.
What company stages does Korea Investment Partners focus on?
Korea Investment Partners typically invests at the Early stage.
What is Korea Investment Partners's AUM?
Korea Investment Partners's assets under management are estimated between $3.3B and $3.5B.